ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CHRISTOPHER HARPER MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 297 out of 780

$557K Total Retail Price of All Prescriptions

Rank: 263 out of 780

411 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 411 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 411 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 5,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 627 220 S3 1 1
LISINOPRIL 333 172 2 6
SIMVASTATIN 298 218 3 2
TRAMADOL HCL 295 137 4 15
LEVOTHYROXINE SODIUM 285 197 5 5
OMEPRAZOLE 264 142 6 3
PRAVASTATIN SODIUM 253 146 7 9
CARVEDILOL 246 212 8 14
METFORMIN HCL 220 151 9 8
GABAPENTIN 192 70 10 13
RANITIDINE HCL 166 100 11 39
FENOFIBRATE 159 75 12 63
CITALOPRAM HBR 149 57 13 23
AMLODIPINE BESYLATE 141 93 14 4
LOSARTAN POTASSIUM 138 111 15 18
FUROSEMIDE 134 108 16 7
ATORVASTATIN CALCIUM 132 60 17 12
METOPROLOL SUCCINATE 124 57 18 20
AMITRIPTYLINE HCL 114 72 R 19 48
TRAZODONE HCL 113 35 20 35
NEXIUM 104 35 21 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 60 22 26
METOPROLOL TARTRATE 100 77 22 19
LOVASTATIN 99 75 24 47
CYCLOBENZAPRINE HCL 98 26 R 25 42
WARFARIN SODIUM 98 94 25 24
MELOXICAM 98 31 25 16
PROMETHAZINE HCL 93 18 R 28 66
DOXEPIN HCL 91 39 29 170
PANTOPRAZOLE SODIUM 87 47 30 25
AZITHROMYCIN 87 44 30 38
PROAIR HFA 87 43 30 62
LOSARTAN-HYDROCHLOROTHIAZIDE 87 70 30 33
POTASSIUM CHLORIDE 85 71 34 11
HYDROCHLOROTHIAZIDE 81 69 35 10
FLUTICASONE PROPIONATE 80 36 36 41
ZOLPIDEM TARTRATE 77 0 37 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 45 38 88
CYMBALTA 69 0 39 51
VENLAFAXINE HCL ER 68 26 40 117
TAMSULOSIN HCL 67 61 41 36
ROPINIROLE HCL 66 18 42 87
PREDNISONE 64 25 43 40
FENTANYL 61 20 S2 44 107
ALENDRONATE SODIUM 61 49 44 44
SPIRIVA 60 27 46 72
SERTRALINE HCL 58 35 47 27
ATENOLOL 58 21 47 21
LYRICA 51 12 49 52
CLOPIDOGREL 50 38 50 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.